1-800-729-1232

gallbladder

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

Product Liability / April 22, 2024 / 4 minutes of reading / By / , , , , , , , , , , ,

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), for weight loss and diabetes management. These drugs have been aggressively promoted by their manufacturers as safe and effective. However, a growing number of former …

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More »

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit

Product Liability / April 5, 2024 / 4 minutes of reading / By / , , , , , , , , , ,

A lawsuit filed late last month in the U.S. District Court for the Eastern District of Pennsylvania sheds light on the potential severity of the gastrointestinal side effects allegedly linked to the popular diabetes and weight-loss drug Ozempic. The lawsuit was filed by Miquana Renteria, a Texas woman who alleges that Ozempic manufacturer Novo Nordisk …

Ozempic Use Led to Gastrointestinal Side Effects, Gallbladder Removal: Lawsuit Read More »

Wegovy: A Look at Weight Loss, Profits, and Controversies

Product Liability / September 19, 2023 / 3 minutes of reading / By / , , , , , ,

In a world where obesity is on the rise and millions are seeking solutions, weight loss drugs have become a multi-billion-dollar industry. One such medication making headlines is Wegovy, a prescription injection manufactured by Novo Nordisk. Touted as a groundbreaking weight loss solution, Wegovy has its fair share of proponents and critics alike. This article …

Wegovy: A Look at Weight Loss, Profits, and Controversies Read More »

Scroll to Top